VEEV pre-earnings setup: Veeva Systems reports earnings on Nov 25, 2026, 16 days out of our Nov 9 morning scan, and the row carries a score of 79 at rank 18 of the 51 names we track. The scan price was $305.97, twenty of twenty-nine ratings are on the buy side, and the options market is pricing one of the narrowest events on the board at 3.8% over three days.

The shape of that setup is unusual for a name this well covered. The priced move is small, the trailing multiple is the seventh highest of the forty-one we publish, and the forward figure on the row leans on a 68.2% jump in estimated earnings per share.

When does VEEV report earnings, and is it a buy before the print?

Veeva reports on Nov 25, 2026, 16 days from the November 9 morning scan, which carried the row with the print date set to November 25 and 16 days left on it.

On what this scanner measures, it is a candidate. The coverage, the strong-buy count and the sentiment reading are all near their ceilings, and the position on the price is close to a month high. The two things arguing against it are the multiple and the fact that the priced event is narrow.

The row, 16 days out

Score 79 at rank 18 of 51, sector Healthcare, print date November 25, earnings sentiment Positive, short interest 2.8% of float, market capitalization $49.54 billion, implied volatility 51.9, and a scan price of $305.97.

Decomposed, the 79 is 25 points for analyst coverage, 17.2 for a 69.0% buy-side share, 14 for the 7 strong buys, 8.1 for an 8.1% fourteen-day implied move, and the full 15 for a Positive sentiment reading. That totals 79.3.

The strong-buy column is the unusual part. Seven strong buys is worth 14 of the 20 points that column can award, and only ten names on our table carry seven or more.

One of the narrowest events on the board

The chain cost $22.00 at the money, which is 7.2% of the share price, and it was quoted on an expiry 11 days out. Implied volatility is 51.9, the sixth calmest reading of the 51 rows we scan.

Scaled off that straddle, the market is pricing 3.8% over three days, 5.7% over seven and 8.1% over fourteen. Around the $305.97 scan price that is a band of $294.48 to $317.46 at three days and $281.15 to $330.79 at fourteen.

Only four names price a narrower three-day move: SLAB at 0.6%, IQ at 1.9%, DIS at 2.4% and NTNX at 2.8%. Veeva is the fifth narrowest of the 51.

There is a catch in the quote itself. The chain expires in 11 days and the print is 16 days away, so the priced band is an estimate of the event rather than a quote on it. The gap between what the chain says and what the print delivers is where a surprise would have to live.

The multiple that needs the forward number

At 50.2 times trailing earnings, Veeva is the seventh most expensive name on the board with a published trailing multiple, behind CRWD at 3,661.2, PANW at 800.5, MDB at 436.8, OKTA at 102.1, SNPS at 79.8 and NCNO at 71.2.

The forward number is 29.8 times, the tenth most expensive of the 51, and that only works if the estimates hold. Trailing earnings per share are $6.10 against $10.26 forward, a gap of 68.2% that has to be delivered.

The PEG of 1.17 sits in the middle of the table. It is a number that cannot be read on its own, because the growth it divides is the same 68.2% the forward multiple depends on.

What the analyst book says

Twenty-nine ratings: 7 strong buys, 13 buys, 8 holds and a single sell. That is 69.0% on the buy side, level with DELL, and behind BILI at 96.7%, NVDA at 93.5% and ADI at 91.2%.

The conviction column is worth 17.2 of the 25 points it can award, which is what a 69.0% buy-side share earns on a book this size. Veeva is not short of coverage; it is short of the unqualified enthusiasm the top of the table shows.

The news feed on our own row carried a broker price-target change, with BTIG moving its Veeva target to $360. That is a broker's view of a year from here, and the options market is pricing something much smaller for the next three days.

Where the price has been sitting this month

The settled closes show Veeva holding a range rather than trending. It closed at $296.13 on Oct 9, ran to $323.04 on Oct 23, and came back to $303.73 by Nov 6.

That last session was down 2.05% on the day and 2.95% over the week, and the month is 2.57% higher overall. The low close of the past month was $295.85 on Oct 12, so the stock is 2.6% above the floor of its own range.

Our 6:33 a.m. PT scan had it at $305.97, 0.72% above the Nov 6 close and within a percent of the month's high close of $323.04. There is no gap to fill here, which is what a narrow priced event usually means.

What has to change before the November 25 print

The event is the lever, and it is the quietest one on the board. At 8.1 points the implied move is worth the least in this comparison, and a wider straddle before the print would lift the score on its own.

The price is the second lever. The stock is 2.57% higher on the month and 5.3% below its own high close, so there is room to run into the print without breaking the range.

What is not a lever is the book or the sentiment reading. Seven strong buys and a Positive sentiment reading are already in the score, and neither of them changes before Nov 25.

The row this page is built from is rebuilt every morning at 6:33 a.m. PT and published at our open data.

So VEEV pre-earnings setup is a score of 79 with 29 ratings on it, seven strong buys, and the fifth narrowest priced event on the table, going into a print 16 days out at 50.2 times trailing earnings.

Whether that makes Veeva a buy before the print is a judgment for the reader, and this page does not make it for them.

Questions on Veeva before the November 25 print

When does VEEV report earnings?

On November 25, 2026, 16 days from the November 9 morning scan. Deere prints on the same date, and the two are the only names on our table with November 25 set on their row.

How much movement is priced into November 25?

3.8% over three days, 5.7% over seven and 8.1% over fourteen, off a $22.00 straddle on an expiry 11 days out. Around the $305.97 scan price that is $294.48 to $317.46 at three days.

Is Veeva expensive against the table?

50.2 times trailing earnings is the seventh highest of the 41 names with a published trailing multiple, and 29.8 times forward is the tenth highest of the 51. Both numbers lean on estimated earnings per share rising from $6.10 to $10.26.